UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy

Alimentary pharmacology & therapeutics, 2001-02, Vol.15 (2), p.163-169

2001

Volltextzugriff (PDF)

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients

Clinical microbiology and infection, 2015-01, Vol.21 (1), p.103.e7-103.e10

2015

Volltextzugriff (PDF)

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up

Clinical microbiology and infection, 2013-12, Vol.19 (12), p.E542-E544

2013

Volltextzugriff (PDF)

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes

Proceedings of the National Academy of Sciences - PNAS, 2019-07, Vol.116 (30), p.15140-15149

2019

Volltextzugriff (PDF)

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption

Clinical microbiology and infection, 2011-06, Vol.17 (6), p.928-934

2011

Volltextzugriff (PDF)

Effect of Lactobacillus GG Supplementation on Antibiotic-Associated Gastrointestinal Side Effects during Helicobacter pylori Eradication Therapy: A Pilot Study

Digestion, 2001-01, Vol.63 (1), p.1-7

2001

Volltextzugriff (PDF)

Rifabutin‐based Helicobacter pylori eradication ‘rescue therapy’

Alimentary pharmacology & therapeutics, 2001-01, Vol.15 (1), p.143-143

2001

Volltextzugriff (PDF)

P171 Rescuing Intestinal Stem Cells via TMEM219 inhibition promotes mucosal healing in Crohn’s disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i477-i477

2024

Volltextzugriff (PDF)

Increased iNKT17 Cell Frequency in the Intestine of Non-Obese Diabetic Mice Correlates With High Bacterioidales and Low Clostridiales Abundance

Frontiers in immunology, 2018-07, Vol.9, p.1752-1752

2018

Volltextzugriff (PDF)

In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir

Journal of antimicrobial chemotherapy, 2013-11, Vol.68 (11), p.2525-2532

2013

Volltextzugriff (PDF)

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

AIDS (London), 2009-02, Vol.23 (4), p.455-460

2009

Volltextzugriff (PDF)

Re: Testicular Microbiome in Azoospermic Men-First Evidence of the Impact of an Altered Microenvironment

The Journal of urology, 2019-04, Vol.201 (4), p.653-653

Niederberger, Craig

2019

Volltextzugriff (PDF)

Probiotics and Helicobacter pylori eradication

Digestive and liver disease, 2002-09, Vol.34, p.S81-S83

2002

Volltextzugriff (PDF)

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

AIDS (London), 2010-03, Vol.24 (6), p.924-928

2010

Volltextzugriff (PDF)

Coronaviridae and SARS-associated coronavirus strain HSR1

Emerging infectious diseases, 2004-03, Vol.10 (3), p.413-418

2004

Volltextzugriff (PDF)

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

Journal of antimicrobial chemotherapy, 2012-01, Vol.67 (1), p.213-217

2012

Volltextzugriff (PDF)

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1224-1227

2012

Volltextzugriff (PDF)

Phage display for the production of human monoclonal antibodies against human pathogens

The New microbiologica, 2004-10, Vol.27 (4), p.315

2004

Volltextzugriff (PDF)

Persistent Symptomless Human Metapneumovirus Infection in Hematopoietic Stem Cell Transplant Recipients

The Journal of infectious diseases, 2006-08, Vol.194 (4), p.474-478

2006

Volltextzugriff (PDF)

Intra-host evolution of human immunodeficiency virus type 1 and viral fitness

The New microbiologica, 2004-04, Vol.27 (2 Suppl 1), p.41

2004

Volltextzugriff (PDF)

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments

The New microbiologica, 2012-07, Vol.35 (3), p.289-294

2012

Volltextzugriff (PDF)

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients: Virology

Clinical microbiology and infection, 2015-01, Vol.21 (1), p.103.e7-103.e10

2015

Volltextzugriff (PDF)

Phylogenetic internal control for HIV-1 genotypic antiretroviral testing

The New microbiologica, 2004-04, Vol.27 (2 Suppl 1), p.105

2004

Volltextzugriff (PDF)

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL--authors' response

Journal of antimicrobial chemotherapy, 2012-10, Vol.67 (10), p.2541-2542

2012

Volltextzugriff (PDF)

Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus

Journal of biological regulators and homeostatic agents, 2003-04, Vol.17 (2), p.198

2003

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(66)
Tagungsberichte
(1)

Sprache

Englisch
(65)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption

Effect of Lactobacillus GG Supplementation on Antibiotic-Associated Gastrointestinal Side Effects during Helicobacter pylori Eradication Therapy: A Pilot Study

Rifabutin‐based Helicobacter pylori eradication ‘rescue therapy’

P171 Rescuing Intestinal Stem Cells via TMEM219 inhibition promotes mucosal healing in Crohn’s disease

Increased iNKT17 Cell Frequency in the Intestine of Non-Obese Diabetic Mice Correlates With High Bacterioidales and Low Clostridiales Abundance

In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

Re: Testicular Microbiome in Azoospermic Men-First Evidence of the Impact of an Altered Microenvironment

Probiotics and Helicobacter pylori eradication

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

Coronaviridae and SARS-associated coronavirus strain HSR1

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

Phage display for the production of human monoclonal antibodies against human pathogens

Persistent Symptomless Human Metapneumovirus Infection in Hematopoietic Stem Cell Transplant Recipients

Intra-host evolution of human immunodeficiency virus type 1 and viral fitness

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients: Virology

Phylogenetic internal control for HIV-1 genotypic antiretroviral testing

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL--authors' response

Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus

Suchergebnisse filtern